IRIS
BOSSI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.779
NA - Nord America 3.297
SA - Sud America 1.413
EU - Europa 566
AF - Africa 118
OC - Oceania 5
Totale 10.178
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.271
US - Stati Uniti d'America 3.145
BR - Brasile 1.210
CN - Cina 734
VN - Vietnam 250
IT - Italia 158
HK - Hong Kong 145
IN - India 90
GB - Regno Unito 88
DE - Germania 84
CA - Canada 78
AR - Argentina 76
MX - Messico 51
BD - Bangladesh 48
ZA - Sudafrica 46
EC - Ecuador 39
TR - Turchia 36
ID - Indonesia 35
ES - Italia 33
PL - Polonia 28
RU - Federazione Russa 27
VE - Venezuela 25
JP - Giappone 22
UZ - Uzbekistan 22
FR - Francia 21
IQ - Iraq 21
SE - Svezia 21
CO - Colombia 20
NL - Olanda 20
UA - Ucraina 19
MA - Marocco 18
PK - Pakistan 16
CL - Cile 14
KE - Kenya 14
FI - Finlandia 12
TN - Tunisia 12
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 9
UY - Uruguay 9
AT - Austria 8
IR - Iran 8
LT - Lituania 8
EG - Egitto 7
IE - Irlanda 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
TW - Taiwan 7
ET - Etiopia 6
JO - Giordania 6
AL - Albania 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
DZ - Algeria 4
GE - Georgia 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
AU - Australia 3
BB - Barbados 3
BH - Bahrain 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BE - Belgio 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
GD - Grenada 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
Totale 10.174
Salva come PNG Salva come JPEG
Città #
Singapore 942
The Dalles 895
Shanghai 515
Dallas 483
Ashburn 365
Beijing 147
Hong Kong 135
Ho Chi Minh City 103
São Paulo 97
Seattle 85
Los Angeles 74
New York 50
Hanoi 47
Santa Clara 46
Boardman 35
Rio de Janeiro 35
Assago 34
Johannesburg 34
Milan 34
Atlanta 33
Curitiba 32
Montreal 32
Munich 30
Brooklyn 27
Naples 27
San Francisco 27
Warsaw 26
Council Bluffs 24
Tashkent 22
Belo Horizonte 21
Campinas 21
Brasília 20
Chicago 20
London 19
Stockholm 19
Mexico City 18
Phoenix 18
Tokyo 18
Boston 17
Chennai 17
Ribeirão Preto 17
Orem 16
Secaucus 16
Denver 15
Guayaquil 15
Buffalo 14
Goiânia 13
Nairobi 13
Chandler 12
Ankara 11
Mumbai 11
New Delhi 11
Poplar 11
Porto Alegre 11
Quito 11
Salvador 11
Caracas 10
Fortaleza 10
Toronto 10
Charlotte 9
Dhaka 9
Haiphong 9
Manchester 9
Santo André 9
Vancouver 9
Amsterdam 8
Betim 8
Düsseldorf 8
Helsinki 8
Jakarta 8
Karachi 8
Montevideo 8
Sorocaba 8
Tunis 8
Volta Redonda 8
Biên Hòa 7
Blumenau 7
Bogotá 7
Buenos Aires 7
Caxias do Sul 7
Cotia 7
Dublin 7
Guarulhos 7
Hải Dương 7
Las Vegas 7
Manaus 7
Nuremberg 7
Osasco 7
Reston 7
Santiago 7
São Bernardo do Campo 7
Vitória da Conquista 7
Addis Ababa 6
Asunción 6
Bengaluru 6
Canoas 6
Genoa 6
Houston 6
Mauá 6
Pelotas 6
Totale 5.183
Salva come PNG Salva come JPEG
Nome #
New trends in supportive care of head and neck cancers 93
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis 88
Ectopic olfactory neuroblastoma is associated with increased frequency of syndrome of inappropriate antidiuretic hormone secretion and reduced disease control: Case series with systematic review and pooled analysis 76
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 75
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck 74
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 68
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 65
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 64
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 54
USO DI MIRNA COME BIOMARCATORI PER LA DIAGNOSI E PROGNOSI DEL CARCINOMA ORALE A CELLULE SQUAMOSE 50
The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey 46
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis 45
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 45
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 45
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 44
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study 43
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 43
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 42
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 42
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety 39
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 38
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 38
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 37
A case of otoliquorrhoea secondary to immunotherapy response in head and neck cutaneous squamous cell carcinoma. When abrupt response may worry the physician 36
Editorial: Understanding and treating rare nasal and paranasal sinus cancers 36
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 36
Computer Vision Foundation Models in Endoscopy: Proof of Concept in Oropharyngeal Cancer 36
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 36
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches 36
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 36
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma 35
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 35
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 35
Diving into hot topics of salivary gland carcinoma management—an EORTC young and early career investigator survey 35
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity 35
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 34
Precision medicine in head and neck cancer: from immunotherapy to microbiota, circulating DNA and robotic surgery 34
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 34
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents 34
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 34
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 33
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 33
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 33
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 33
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework 33
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 33
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 33
HoW reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group (vol 152, 106744, 2024) 32
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 32
The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw 32
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 32
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 31
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 31
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 31
New insights in chemotherapy 31
The use of fentanyl in pain management in head and neck cancer patients: a narrative review 31
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines 31
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 30
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 30
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 30
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 30
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 29
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 29
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 29
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy 29
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 29
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study) 29
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 29
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 29
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 29
Treatment Options for Recurrent Anterior Skull Base Tumors 29
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial 29
Fragile Histidine Triad Gene Inactivation in Lung Cancer The European Early Lung Cancer Project 29
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma 29
Bridging gaps in cancer cachexia Care: Current insights and future perspectives 29
Quality Assessment in Supportive Care in Head and Neck Cancer 29
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? 28
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 28
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 28
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods 28
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling 28
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 28
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area 28
Nodal status in major salivary gland cancer: External validation of a novel N- classification 28
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 28
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations 28
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 28
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study 28
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 28
Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action 28
PROGNOSTIC FACTORS INFLUENCING OUTCOME OF PATIENTS WITH RECURRENT OR METASTATIC CARCINOMA (RandM) OF THE HEAD AND NECK: RESULTS OF AN ITALIAN MONOINSTITUTIONAL STUDY 28
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 28
TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC) 28
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 27
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 27
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? 27
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 27
May we rely on induction chemotherapy again as a biological selection of radiosensitive head and neck cancer? 27
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 27
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 27
Totale 3.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 3 1 1 2 1 0 2
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.254 2 2 6 0 0 0 1 434 43 53 251 462
2024/20254.244 138 26 56 86 45 395 214 189 825 1.141 533 596
2025/20265.093 1.797 902 705 992 466 231 0 0 0 0 0 0
Totale 10.639